Home | Welcome to Contract Pharma   
Last Updated Monday, December 22 2014

Print RSS Feed

Topics - Drug Delivery

Refine by Date:
From: To:
Published December 17, 2014
Amunix will receive an option fee and is eligible for additional milestones Read More »
Published December 17, 2014
To develop and commercialize Janssen products with ENHANZE technology Read More »
Published December 4, 2014
Will support the development and reprofiling of zolpidem using Catalent’s OSDrC OptiDose Read More »
Published November 14, 2014
Adds global particle size engineering technologies Read More »
Published November 13, 2014
To discover and develop new delivery methods for antisense oligonucleotides Read More »
Published October 8, 2014
Combined offering to provide electronically-connected drug delivery systems Read More »
Published October 7, 2014
New technology offers bioavailability enhancement and modified release suites Read More »
Published May 23, 2014
Will evaluate data and define the studies to further characterize safety and efficacy Read More »
Published May 19, 2014
To employ AntiOp’s nasal drug delivery expertise Read More »
Published April 3, 2014
Diabetes drug employs Novozymes VELTIS extension technology Read More »
By Kristin Brooks
Published March 26, 2014
Will use NanoStat platform for RSV and flu vaccine development Read More »
By Kristin Brooks
Published March 17, 2014
Will evaluate biOasis' Transcend brain delivery platform on preclinical assets Read More »
By Kristin Brooks
Published February 24, 2014
Designed to help improve consistency and reliability of intradermal injections Read More »
By Kristin Brooks
Published January 24, 2014
Aims to accelerate research and drug delivery technologies Read More »
By Kristin Brooks
Published January 15, 2014
Offers technical resources and information on ODT platform Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On